Patents by Inventor David S. Alburty

David S. Alburty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230146816
    Abstract: Devices, systems, and methods are disclosed which relate to using a use large area surface sampler with invertible bag for collection of biological and non-biological particles prior to subsequent analysis. The large area surface sampler with invertible bag uses an inverted bag with bonded sampling material to first serve as a sampling device followed by the bag being turned right side out and the captured particles being extracted inside of the bag. The device includes measures for sealing liquid in the sampling material using a protective cup at time of manufacture. This enables users to simply remove the protective cup and perform wet surface sampling prior to turning the bag right side out and removing captured particles from the sampling material with repeated compressions.
    Type: Application
    Filed: November 9, 2022
    Publication date: May 11, 2023
    Inventors: Michael Fischer, Bryan Long, Steven D. Graham, Sidney J. Spry, Alec Adolphson, John D. Birkenholz, Andrew E. Page, David S. Alburty
  • Publication number: 20220125333
    Abstract: Devices and methods are described for using normal human breath to separately capture particles from inhaled and exhaled breath for analysis. This device can be constructed as a wearable device worn as a mask with separately removable filters on the inside and the outside of an efficient collection material.
    Type: Application
    Filed: October 26, 2021
    Publication date: April 28, 2022
    Inventors: David S. Alburty, Andew E. Page, John D. Birkenholz, Kathleen Ruegsegger, Ann K. Packingham, Zachary A. Packingham, Alec D. Adolphson, Pamela S. Murowchick, Hugh Olsen, Bryan C. Long, Steven D. Graham
  • Publication number: 20210308664
    Abstract: Highly efficient and rapid filtration-based concentration devices, systems and methods are disclosed with sample fluidic lines and a filter packaged in a disposable tip which concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. The concentrate is then dispensed from the disposable tip in a set volume of elution fluid. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect and identify. A single-use pipette tip includes fluid ports for aspirating the sample and connecting to a concentrating unit.
    Type: Application
    Filed: April 5, 2021
    Publication date: October 7, 2021
    Inventors: John D. Birkenholz, Andrew Edward Page, Zachary A. Packingham, David S. Alburty, Alec D. Adolphson, Steven Dale Graham, Michael F. Fischer
  • Publication number: 20210077080
    Abstract: Devices, systems and methods are disclosed which relate to using wet foam elution for removal of particles from swabs and wipes. This allow users to capture particles from surfaces and recover them by elution into small sample volumes for subsequent detection for human clinical, veterinary, food safety, pharmaceutical, outbreak investigations, forensics, biodefense and bioterrorism response, environmental monitoring, and other applications where collection of samples from surfaces and humans or animals is required. More specifically, the swabs or wipes are used to collect samples in the standard ways that commercially available swabs and wipes are in use today; from, for instance, food preparation surfaces in food plants, from production equipment in pharmaceutical facilities, for collection of dry powders during bioterrorism event response, and for collection of clinical samples such as nasal, throat, nasopharyngeal, and wounds.
    Type: Application
    Filed: November 24, 2020
    Publication date: March 18, 2021
    Inventors: Alec D. Adolphson, Ann K. Packingham, Andrew E. Page, David S. Alburty, Zachary A. Packingham, John D. Birkenholz, Michael F. Fischer
  • Patent number: 10842470
    Abstract: Devices, systems and methods are disclosed which relate to using wet foam elution for removal of particles from swabs and wipes. This allow users to capture particles from surfaces and recover them by elution into small sample volumes for subsequent detection for human clinical, veterinary, food safety, pharmaceutical, outbreak investigations, forensics, biodefense and bioterrorism response, environmental monitoring, and other applications where collection of samples from surfaces and humans or animals is required. More specifically, the swabs or wipes are used to collect samples in the standard ways that commercially available swabs and wipes are in use today; from, for instance, food preparation surfaces in food plants, from production equipment in pharmaceutical facilities, for collection of dry powders during bioterrorism event response, and for collection of clinical samples such as nasal, throat, nasopharyngeal, and wounds.
    Type: Grant
    Filed: April 18, 2016
    Date of Patent: November 24, 2020
    Assignee: INNOVAPREP, LLC
    Inventors: Alec D. Adolphson, Ann K. Packingham, Andrew E. Page, David S. Alburty, Zachary A. Packingham, John D. Birkenholz, Michael F. Fischer
  • Publication number: 20200224242
    Abstract: A rapid one-pass liquid filtration system efficiently concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect. Additional concentration stages may be added in “cascade” fashion, in order to concentrate particles below the size cut of each preceding stage remaining in the separated fluid in a concentrated sample suspension. This process can also be used to create a “band-pass” concentration for concentration of a particular target size particle within a narrow range.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 16, 2020
    Inventors: David S. Alburty, Andrew E. Page, Zachary A. Packingham, Daniel B. Marske
  • Patent number: 10544445
    Abstract: A rapid one-pass liquid filtration system efficiently concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect. Additional concentration stages may be added in “cascade” fashion, in order to concentrate particles below the size cut of each preceding stage remaining in the separated fluid in a concentrated sample suspension. This process can also be used to create a “band-pass” concentration for concentration of a particular target size particle within a narrow range.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: January 28, 2020
    Assignee: InnovaPrep, LLC
    Inventors: David S. Alburty, Andrew E. Page, Zachary A. Packingham, Daniel B. Marske
  • Publication number: 20170369925
    Abstract: A rapid one-pass liquid filtration system efficiently concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect. Additional concentration stages may be added in “cascade” fashion, in order to concentrate particles below the size cut of each preceding stage remaining in the separated fluid in a concentrated sample suspension. This process can also be used to create a “band-pass” concentration for concentration of a particular target size particle within a narrow range.
    Type: Application
    Filed: August 18, 2017
    Publication date: December 28, 2017
    Inventors: David S. Alburty, Andrew E. Page, Zachary A. Packingham, Daniel B. Marske
  • Patent number: 9738918
    Abstract: A rapid one-pass liquid filtration system efficiently concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect. Additional concentration stages may be added in “cascade” fashion, in order to concentrate particles below the size cut of each preceding stage remaining in the separated fluid in a concentrated sample suspension. This process can also be used to create a “band-pass” concentration for concentration of a particular target size particle within a narrow range.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: August 22, 2017
    Assignee: InnovaPrep, LLC
    Inventors: David S. Alburty, Andrew E. Page, Zachary A. Packingham, Daniel B. Marske
  • Publication number: 20160302776
    Abstract: Devices, systems and methods are disclosed which relate to using wet foam elution for removal of particles from swabs and wipes. This allow users to capture particles from surfaces and recover them by elution into small sample volumes for subsequent detection for human clinical, veterinary, food safety, pharmaceutical, outbreak investigations, forensics, biodefense and bioterrorism response, environmental monitoring, and other applications where collection of samples from surfaces and humans or animals is required. More specifically, the swabs or wipes are used to collect samples in the standard ways that commercially available swabs and wipes are in use today; from, for instance, food preparation surfaces in food plants, from production equipment in pharmaceutical facilities, for collection of dry powders during bioterrorism event response, and for collection of clinical samples such as nasal, throat, nasopharyngeal, and wounds.
    Type: Application
    Filed: April 18, 2016
    Publication date: October 20, 2016
    Inventors: Alec D. Adolphson, Ann K. Packingham, Andrew E. Page, David S. Alburty, Zachary A. Packingham, John D. Birkenholz, Michael F. Fischer
  • Publication number: 20140308659
    Abstract: A rapid one-pass liquid filtration system efficiently concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect. Additional concentration stages may be added in “cascade” fashion, in order to concentrate particles below the size cut of each preceding stage remaining in the separated fluid in a concentrated sample suspension. This process can also be used to create a “band-pass” concentration for concentration of a particular target size particle within a narrow range.
    Type: Application
    Filed: June 24, 2014
    Publication date: October 16, 2014
    Applicant: INNOVAPREP LLC
    Inventors: David S. Alburty, Andrew E. Page, Zachary A. Packingham, Daniel B. Marske
  • Publication number: 20140186819
    Abstract: A rapid one-pass liquid filtration system efficiently concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect. Additional concentration stages may be added in “cascade” fashion, in order to concentrate particles below the size cut of each preceding stage remaining in the separated fluid in a concentrated sample suspension. This process can also be used to create a “band-pass” concentration for concentration of a particular target size particle within a narrow range.
    Type: Application
    Filed: February 7, 2012
    Publication date: July 3, 2014
    Inventors: David S. Alburty, Andrew E. Page, Zachary A. Packingham, Daniel B. Marske
  • Patent number: 8758623
    Abstract: A rapid one-pass liquid filtration system efficiently concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect. Additional concentration stages may be added in “cascade” fashion, in order to concentrate particles below the size cut of each preceding stage remaining in the separated fluid in a concentrated sample suspension. This process can also be used to create a “band-pass” concentration for concentration of a particular target size particle within a narrow range.
    Type: Grant
    Filed: February 7, 2012
    Date of Patent: June 24, 2014
    Assignee: InnovaPrep LLC
    Inventors: David S. Alburty, Andrew E. Page, Zachary A. Packingham, Daniel B. Marske
  • Patent number: 8110112
    Abstract: A rapid one-pass liquid filtration system efficiently concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect. Additional concentration stages may be added in “cascade” fashion, in order to concentrate particles below the size cut of each preceding stage remaining in the separated fluid in a concentrated sample suspension. This process can also be used to create a “band-pass” concentration for concentration of a particular target size particle within a narrow range.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: February 7, 2012
    Assignee: Innova Prep LLC
    Inventors: David S. Alburty, Andrew E. Page, Zachary A. Packingham, Daniel B. Marske
  • Publication number: 20090101575
    Abstract: A rapid one-pass liquid filtration system efficiently concentrates biological particles that are suspended in liquid from a dilute feed suspension. A sample concentrate or retentate suspension is retained while eliminating the separated fluid in a separate flow stream. Suspended biological particles include such materials as proteins/toxins, viruses, DNA, and/or bacteria in the size range of approximately 0.001 micron to 20 microns diameter. Concentration of these particles is advantageous for detection of target particles in a dilute suspension, because concentrating them into a small volume makes them easier to detect. Additional concentration stages may be added in “cascade” fashion, in order to concentrate particles below the size cut of each preceding stage remaining in the separated fluid in a concentrated sample suspension. This process can also be used to create a “band-pass” concentration for concentration of a particular target size particle within a narrow range.
    Type: Application
    Filed: May 30, 2008
    Publication date: April 23, 2009
    Inventors: David S. Alburty, Andrew E. Page, Zachary A. Packingham, Daniel B. Marske
  • Patent number: 7179596
    Abstract: The present invention provides a biological particle analogue, or biological analogue, that simulates a chosen biological organism or compound. The biological analogue includes a first portion that is not, in and of itself, recognized by the biological detection system, and a second portion, which provides the properties necessary for recognition by the detection system, carried by the first portion. The biological analogue is constructed in such a way as to include some important characteristics of the chosen biological organism or compound, while excluding other undesirable characteristics of the chosen biological organism or compound. The present invention is useful in testing a variety of biological detection systems.
    Type: Grant
    Filed: February 17, 2003
    Date of Patent: February 20, 2007
    Assignee: Sceptor Industries, Inc.
    Inventors: Andrew E. Page, Kelly L Brown, David S. Alburty, Robert C. Huebner
  • Publication number: 20040191770
    Abstract: The present invention provides a biological particle analogue, or biological analogue, that simulates a chosen biological organism or compound. The biological analogue includes a first portion that is not, in and of itself, recognized by the biological detection system, and a second portion, which provides the properties necessary for recognition by the detection system, carried by the first portion. The biological analogue is constructed in such a way as to include some important characteristics of the chosen biological organism or compound, while excluding other undesirable characteristics of the chosen biological organism or compound. The present invention is useful in testing a variety of biological detection systems.
    Type: Application
    Filed: February 17, 2003
    Publication date: September 30, 2004
    Applicant: MIDWEST RESEARCH INSTITUTE, INC.
    Inventors: Andrew E. Page, Kelly L Brown, David S. Alburty, Robert C. Huebner
  • Patent number: D688805
    Type: Grant
    Filed: December 31, 2012
    Date of Patent: August 27, 2013
    Assignee: InnovaPrep LLC
    Inventors: Andrew E Page, Zachary A Packingham, David S Alburty, Alec D Adolphson
  • Patent number: D731634
    Type: Grant
    Filed: December 31, 2012
    Date of Patent: June 9, 2015
    Assignee: Innovaprep LLC
    Inventors: Andrew E Page, Zachary A Packingham, David S Alburty, Pamela S Murowchick, Alec D Adolphson